CompanyScope

Guardant Health, Inc. revenue by year

Ticker GH · SEC CIK 1576280 · Latest fiscal year ended Dec 31, 2025

Over the 10 fiscal years shown, revenue went from $25.25M (year ended Dec 31, 2016) to $982.02M (year ended Dec 31, 2025), a compound annual growth rate of 50.2%. The fastest growth was +136.5% in the year ended Dec 31, 2019; the weakest year was +20.3% (year ended Dec 31, 2022).

$0$250M$500M$750M$1BDec 2016: $25.25MDec 2017: $49.84MDec 2018: $90.64MDec 2019: $214.38MDec 2020: $286.73MDec 2021: $373.65MDec 2022: $449.54MDec 2023: $563.95MDec 2024: $739.02MDec 2025: $982.02MDec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Guardant Health, Inc. revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$982.02M+32.9%Revenues10-K filed Feb 19, 2026
Dec 31, 2024$739.02M+31.0%Revenues10-K filed Feb 19, 2026
Dec 31, 2023$563.95M+25.5%Revenues10-K filed Feb 19, 2026
Dec 31, 2022$449.54M+20.3%Revenues10-K filed Feb 20, 2025
Dec 31, 2021$373.65M+30.3%Revenues10-K filed Feb 22, 2024
Dec 31, 2020$286.73M+33.8%Revenues10-K filed Feb 23, 2023
Dec 31, 2019$214.38M+136.5%Revenues10-K filed Feb 24, 2022
Dec 31, 2018$90.64M+81.9%Revenues10-K filed Feb 25, 2021
Dec 31, 2017$49.84M+97.4%Revenues10-K filed Mar 2, 2020
Dec 31, 2016$25.25M—Revenues10-K filed Mar 19, 2019

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Jun 30, 2026$334.98M+44.3%10-Q filed Jul 30, 2026
3 months ended Mar 31, 2026$301.67M+48.3%10-Q filed May 7, 2026
3 months ended Sep 30, 2025$265.20M+38.5%10-Q filed Oct 29, 2025
3 months ended Jun 30, 2025$232.09M+30.9%10-Q filed Jul 30, 2026
3 months ended Mar 31, 2025$203.47M+20.8%10-Q filed May 7, 2026
3 months ended Sep 30, 2024$191.48M+33.9%10-Q filed Oct 29, 2025
3 months ended Jun 30, 2024$177.24M+29.2%10-Q filed Jul 30, 2025
3 months ended Mar 31, 2024$168.49M+30.9%10-Q filed Apr 30, 2025

Source: SEC EDGAR XBRL company facts for CIK 1576280 (raw data). Most recent filing in this dataset: 10-Q filed Jul 30, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.